Showing 3151-3160 of 5128 results for "".
Vitiligo: Understanding Your Options
https://practicaldermatology.com/youngmd-connect/wrap-ups/vitiligo-understanding-your-options/29890/Showing up is half the battle, it has often been said. According to dermatologist Nanette Silverberg, MD, FAAP, FAAD, chief of pediatric dermatology at Mount Sinai Health System in New York, that adage applied to the attendees at a recent YoungMD Connect virtual session featuring two expert presentaDataDerm Update
https://practicaldermatology.com/topics/practice-management/dataderm-update/23891/Joining can do a lot for your practice and patients.Physician Spotlight: Thomas E. Rohrer, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-thomas-e-rohrer-md/23337/New Products
https://practicaldermatology.com/columns/new-products/newproducts/21023/Physician Spotlight
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight/21039/The media is quick to use the phrase “game changer” whenever a new body-contouring device or technique enters the fray. An expert weighs in.A Rare Case of Linear Darier Disease
https://practicaldermatology.com/youngmd-connect/resident-resource-center/a-rare-case-of-linear-darier-disease/23857/A localized genodermatosis with potential to cause widespread disease in the next generation.Physician Spotlight: Lynn McKinley-Grant, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-1/22990/Currents
https://practicaldermatology.com/topics/practice-management/currents/21190/Speak Up! Advocate for yourself, your patients, your specialty10 Procedural Tips for Hidradenitis Suppurativa
https://practicaldermatology.com/topics/rare-disease/10-procedural-tips-for-hidradenitis-suppurativa/56430/This guide was created to assist dermatologists who care for patients with HS considering surgery and emphasizes the importance of patient-centered care, expectation setting, and advanced surgical techniques.Next-Generation TYK2 Inhibitors in Psoriasis
https://practicaldermatology.com/topics/psoriasis/next-generation-tyk2-inhibitors-in-psoriasis/60985/Phase 3 clinical data and emerging therapeutic implications demonstrate the promise of zasocitinib and envudeucitinib.